Chest
Recent Advances in Chest MedicineGlycemic Control in the ICU
Section snippets
Intensive Insulin Therapy: The Landmark Trials in Leuven
More recently, recognition that hyperglycemia is independently associated with increased ICU mortality,5, 15, 16, 17, 18, 19, 20, 21 and evidence that better control of blood glucose in acute illness can be beneficial,18 has led to the study of tighter blood glucose control in critical care. The first randomized controlled trial compared intensive insulin therapy (IIT) (target blood glucose concentration between 80 and 110 mg/dL [4.4-6.1 mmol/L]) with conventional insulin therapy (target blood
Confirmatory Studies: IIT in Other Single-Center and Multicenter Trials
The encouraging results from Van den Berghe and colleagues1, 22, 26 led many to accept IIT as a standard of care; others suggested a more cautious approach and had concerns about widespread adoption of the treatment. These concerns included the potential for harm from the increased risk of hypoglycemia, and the possibility of bias because the trials in Leuven were unblinded to the investigators and to the clinicians treating the patients. The general applicability of the results was unclear
The Impact of Hypoglycemia
In the NICE-SUGAR trial, the incidence of severe hypoglycemia (blood glucose concentration ≤ 40 mg/dL [2.2 mmol/L]) was significantly higher with IIT.33 Furthermore, because of the very low incidence of severe hypoglycemia in the control group, the relative risk of severe hypoglycemia was 13.7 in patients assigned to IIT, more than twice that seen in prior randomized controlled trials.1, 22, 32, 34 Although no causal link has yet been demonstrated between hypoglycemia and increased mortality,
The Role of Blood Glucose Variability
Blood glucose concentrations vary markedly in critically ill patients, even when using continuous feeding and insulin infusions.53 Even in the presence of the same mean blood glucose value, blood glucose variability can be quite different (Fig 2).
In a retrospective study of 7,049 critically ill patients treated in four centers in Australia, the SD of blood glucose concentration during ICU stay was used as a marker of blood glucose variability; it was significantly higher in patients who died
The Role of Measurement Error
Even though a more modest target for blood glucose is now accepted, the importance of glucose monitoring and its accuracy has become clearer. Most point-of-care (POC) glucose measuring systems were not developed to guide the administration of insulin in critically ill patients, and it has become clear that they are not accurate enough to guide therapy aimed at keeping blood glucose concentration within a 30 mg/dL (1.7 mmol/L) range (Fig 4).68, 69, 70 Better monitoring systems are needed to
Acute Glucose Control in Critically Ill Patients With Diabetes
Current criteria used for the diagnosis of DM are (1) HbA1c level > 6.5% (National Glycohemoglobin Standardization Program certified methods), (2) fasting glucose concentration > 126 mg/dL (7.0 mmol/L), (3) 2-h plasma glucose concentration > 200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test, or (4) classic symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose concentration > 200 mg/dL (11.1 mmol/L).82 Although diagnostic criteria based on HbA1c may be
Glucose Control in 2011: Where Are We Now?
Both the initial Leuven trial and the NICE-SUGAR studies demonstrated that ICU mortality is affected by the target for glucose control, but the studies came to opposing conclusions. The initial enthusiasm for tight glucose control that followed the first Leuven trial has been tempered by the unfavorable findings of the NICE-SUGAR study. The available clinical trial data do not support the widespread adoption of intensive glucose control in critically ill patients, but neither do they support
Recommendations for Future Studies
The recommendations for acute glycemic control described here depend on “manual” glycemic control, accompanied by laboratory-based glucose measurements, usually with an insulin infusion titrated according to protocol. Such systems are very expensive in terms of nursing time and are prone to operator error. New technology is emerging that allows accurate and near-continuous measurement of blood glucose. A variety of systems are currently under development but none is yet in widespread clinical
Conclusions
The marked changes in the evidence guiding glucose control in critically ill patients during this decade have once again shown that promising results in single-center studies may be hard to replicate in large, multicenter, randomized controlled trials. The optimum blood glucose target for critically ill patients remains unclear, but a modest target such as that recommended by the American Diabetes Association (144-180 mg/dL [8-10 mmol/L]) with careful monitoring to avoid hypoglycemia and dosing
Acknowledgments
Financial/nonfinancial disclosures: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
References (98)
Alterations in carbohydrate metabolism during stress: a review of the literature
Am J Med
(1995)- et al.
Stress-induced hyperglycemia
Crit Care Clin
(2001) - et al.
The relationship between blood glucose level and QTc duration in the critically ill
Crit Care Resusc
(2009) - et al.
A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients
Crit Care Resusc
(2006) - et al.
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year
J Am Coll Cardiol
(1995) - et al.
Safety and feasibility of an insulin adjustment protocol to maintain blood glucose concentrations within a narrow range in critically ill patients in an Australian level III adult intensive care unit
Crit Care Resusc
(2004) Intensive insulin therapy in septic shock
Crit Care Resusc
(2006)- et al.
ESPEN Guidelines on Parenteral Nutrition: intensive care
Clin Nutr
(2009) - et al.
Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis
Chest
(2010) - et al.
Hypoglycemia and outcome in critically ill patients
Mayo Clin Proc
(2010)
Role of nitric oxide in the effects of hypoglycemia on the cerebral circulation in awake goats
Eur J Pharmacol
What is a NICE-SUGAR for patients in the intensive care unit?
Mayo Clin Proc
Glucose fluctuation on the progression of diabetic macroangiopathy—new findings from monocyte adhesion to endothelial cells
Diabetes Res Clin Pract
Agreement between bedside blood and plasma glucose measurement in the ICU setting
Chest
Performance of a new interference-resistant glucose meter
Clin Biochem
Critical glucose control: the devil is in the details
Mayo Clin Proc
Effect of an intensive glucose management protocol on the mortality of critically ill adult patients
Mayo Clin Proc
Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus
Mayo Clin Proc
Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital
Semin Thorac Cardiovasc Surg
Intensive insulin therapy in the critically ill patients
N Engl J Med
Perioperative hyperglycemia, infection or risk?
Curr Opin Clin Nutr Metab Care
Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control
AACN Clin Issues
Hyperglycemia in the critically ill patient
AACN Clin Issues
Glucose control and mortality in critically ill patients
JAMA
Relationship of early hyperglycemia to mortality in trauma patients
J Trauma
Hyperglycaemia and mortality in critically ill patients. A prospective study
Intensive Care Med
Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study
Circulation
Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage
Crit Care Med
Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes
Diabetes
Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus
N Engl J Med
The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients
Infect Control Hosp Epidemiol
Perioperative diabetic and hyperglycemic management issues
Crit Care Med
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group
BMJ
Intensive insulin therapy in the medical ICU
N Engl J Med
Statistics in medicine—reporting of subgroup analyses in clinical trials
N Engl J Med
Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control
Crit Care Med
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008
Crit Care Med
Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm
Diabetes
The need to reform our assessment of evidence from clinical trials: a commentary
Philos Ethics Humanit Med
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
JPEN J Parenter Enteral Nutr
Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary
Crit Care Med
Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis
Am J Respir Crit Care Med
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
N Engl J Med
Intensive versus conventional glucose control in critically ill patients
N Engl J Med
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
Intensive Care Med
Benefits and risks of tight glucose control in critically ill adults: a meta-analysis
JAMA
Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data
CMAJ
Nutrition therapy in the critical care setting: what is “best achievable” practice? An international multicenter observational study
Crit Care Med
Cited by (64)
Continuous time recurrent neural networks: Overview and benchmarking at forecasting blood glucose in the intensive care unit
2023, Journal of Biomedical InformaticsThe mediation effects of metabolic and immune–inflammation factors on the depression–premature coronary heart disease association
2023, Journal of Affective DisordersNutritional management of patients treated with continuous renal replacement therapy
2021, Nutritional Management of Renal Disease, Fourth EditionGlycemic control in the intensive care unit: A control systems perspective
2019, Annual Reviews in ControlComparison of 2 intravenous insulin protocols: Glycemia variability in critically ill patients
2017, Endocrinologia, Diabetes y Nutricion
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).